Beyond data collection: The connected device advantage in clinical trials 

Clinical trials have always relied on quality data, but as protocols become more complex and decentralized research becomes more common, data collection is only part of the challenge. Sponsors need to collect high-quality data while keeping participants engaged, minimizing burden on sites, maintaining visibility into study performance, and ensuring confidence in the results. Connected devices help to address these challenges. 

From wearable sensors and mobile technologies to remote physiological monitoring solutions, connected devices allow study teams to collect data beyond the traditional clinic setting. However, while the device often gets attention, the real value comes from everything that happens around it. 

Success depends on more than capturing data. It requires a connected approach that links participants, sites, sponsors, and clinical experts through a seamless flow of information, oversight, and support. 

Moving beyond the device

Connected technologies have expanded what’s possible in clinical research. 

Whether supporting cardiac monitoring, respiratory endpoints, neurological assessments, or other physiological measurements, these tools make it possible to collect data in real-world environments while participants go about their daily lives. 

However, collecting data is only the first step. 

Sponsors also need confidence that devices are working properly, participants are using them correctly, data is being transmitted successfully, and monitoring activities are being completed as required. Potential safety concerns need to be identified quickly, and final datasets must meet both scientific and regulatory expectations. 

Without visibility into these activities, even the most advanced technology can create operational challenges rather than efficiencies. 

The question is no longer whether a device can collect data. The question is whether the entire process surrounding that device can consistently produce high-quality clinical evidence.

Enhancing the participant experience

One of the most significant advantages of connected devices is their ability to create a more participant-centered experience. 

Traditional monitoring approaches often require participants to attend additional site visits, manage complex schedules, and adjust their daily routines around study requirements. These demands can make participation less convenient and more disruptive. 

Connected technologies help offer a more flexible approach. 

Many assessments can now be completed while participants remain at home, at work, or engaged in their normal daily activities. By integrating study procedures more seamlessly into everyday life, connected monitoring enables participants to stay engaged without significantly altering their routines. 

This flexibility can have a meaningful impact on the overall participant experience. 

When participation is more convenient and accessible, participants may find it easier to remain engaged, complete study assessments, and adhere to study requirements. The ability to take part in research with fewer disruptions can foster a more positive study experience while supporting consistent participation throughout the trial. 

The result is often better participant experience and more complete, consistent data collection.

Visibility throughout the study journey

Connected-device sensors and platforms do more than collect data. They provide visibility throughout the study lifecycle. 

Historically, teams often became aware of issues only after data review was completed or when operational problems had already affected study execution. Connected technologies create opportunities for a more proactive approach. 

From enrollment through final reporting, study teams can gain insight into device connectivity, participant adherence, monitoring progress, and overall study performance. 

Participants begin with onboarding, training, and device deployment. As monitoring activities progress, data can be transmitted securely while sponsors and sites maintain visibility of compliance, connectivity, and data quality. 

This visibility can help identify issues earlier, whether it’s missed monitoring sessions, interrupted data transmission, or participant compliance concerns. Addressing potential issues before they affect study outcomes helps preserve both participant engagement and data quality. 

For sponsors and sites, that means less time reacting to problems and more time managing studies effectively. 

Supporting safety though better insight

Patient safety remains a critical priority in every clinical trial. 

Connected monitoring can create opportunities for earlier awareness of information that may require attention. Depending on study requirements, teams may have visibility into device status, participant compliance, data quality indicators, and sometimes even configurable safety notifications. 

While technology does not replace clinical judgment, it can support faster awareness and more informed decision-making for both in-clinic and hybrid trials. 

For sites, this may reduce manual follow-up and administrative oversight. For sponsors, it can provide additional confidence that participants remain engaged, and study activities are progressing as expected. 

Ultimately, greater visibility supports better study management and stronger participant oversight. 

Turning data into evidence

The greatest value of connected devices is not simply the data they collect. It is what happens to that data afterward. 

Raw physiological signals from cardiac and respiratory devices do not become clinical evidence on their own. Before data can support study objectives or development decisions, it must be reviewed, assessed for quality, analyzed, interpreted, and incorporated into meaningful reports and data insights. 

This is where technology and clinical expertise come together. 

The most effective connected-device strategies go beyond data collection, combining advanced technologies with scientific expertise, operational oversight, and clinical review. Together, these capabilities help transform physiological signals into trusted clinical evidence that sponsors can use with confidence. 

In many ways, the success of a connected-device program should not be measured by the volume of data generated. It should be measured by the quality, reliability, and clinical value of the evidence that data produces. 

Looking ahead

Connected technologies are changing how clinical trials are conducted. 

The future of clinical research is not simply about collecting data remotely. It is about creating a more connected research experience that reduces participant burden, improves operational visibility, supports patient safety, and strengthens confidence in study outcomes. 

When connected devices, operational workflows, and clinical expertise work together, sponsors gain more than a monitoring solution. They gain the tools and insights that help reduce operational complexity, improve data quality, and strengthen confidence in study outcomes. 

Connected devices collect the data. Scientific expertise, operational oversight, and clinical review help transform that data into evidence.